Research Analysts’ Updated EPS Estimates for August, 25th (FNF, GASS, GFSZY, GLRE, GMO, GZT, HALO, HDB, HDS, HTCMY)

Research Analysts’ updated eps estimates for Friday, August 25th:

Fidelity National Financial (NYSE:FNF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $54.00 price target on the stock. According to Zacks, “Fidelity National Title Group, Inc. is a leading provider of title insurance, specialty insurance and claims management services. FNT is one of the nation’s largest title insurance companies through its title insurance underwriters. FNT also provides flood insurance, personal lines insurance and home warranty insurance through it specialty insurance business. FNT also is a leading provider of outsourced claims management services to large corporate and public sector entities through its minority-owned subsidiary, Sedgwick CMS. “

StealthGas (NASDAQ:GASS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “StealthGas Inc is a provider of international seaborne transportation services to LPG producers and users. The Company’s vessels carry various petroleum and petrochemical gas products in liquefied form, including propane, butane, butadiene, isopropane, propylene and vinyl chloride monomer, which are all byproducts of the production of oil and natural gas. These products are transported in liquefied form in order to reduce their volume and to facilitate their handling. Transportation by sea represents a major element of gas transportation logistics. LPG products have a variety of both industrial and other uses, including transportation, fertilizer production, the manufacture of plastics, space heating, cooking, water heating and process heating. We serve industrial companies, as well as national and independent energy companies and energy traders. “

G4S (NASDAQ:GFSZY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $21.00 price target on the stock. According to Zacks, “G4S Plc operates as an integrated security company specializing in the provision of security products, services and solutions. It offers secure solutions, including risk services and consultancy services; access control, CCTV, intruder alarms, fire detection, video analytics and security, and building systems technology integration; mobile security patrol and response services, and alarm receiving and monitoring facilities; secure facilities services; assisting long term unemployed people into work; and manned security services. The Company also provides care and justice services; prisoner escorting; asylum services; electronic monitoring; and police services. It has operations in North America, Europe, Africa, Middle East, Asia/Pacific and Latin America. G4S Plc is based in United Kingdom. “

Greenlight Reinsurance (NASDAQ:GLRE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “GREENLIGHT CAPITAL REINSURANCE LTD. is an AM Best A- (Excellent) rated specialty property and casualty reinsurance company based in the Cayman Islands. The Company provides a variety of custom-tailored reinsurance solutions to the insurance, risk retention group, captive and financial marketplaces. Greenlight Re selectively offers customized reinsurance solutions in markets where capacity and alternatives are limited. With a focus on deriving superior returns from both sides of the balance sheet, Greenlight Re’s assets are managed according to a value-oriented equity-focused strategy that complements the Company’s business goal of long-term growth in book value per share. “

General Moly (NYSEMKT:GMO) (TSE:GMO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $0.50 price target on the stock. According to Zacks, “General Moly is a U.S.-based molybdenum mineral exploration and development company listed on the American Stock Exchange and the Toronto Stock Exchange under the symbol GMO. Their primary asset, their interest in the Mt. Hope project located in central Nevada, is considered one of the world’s largest and highest grade molybdenum deposits. Combined with their second molybdenum property, the Hall-Tonopah project which is also located in central Nevada. Their goal is to become the largest primary molybdenum producer by the middle of the next decade. “

Gazit-Globe (NYSE:GZT) (TSE:GZT) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $11.00 target price on the stock. According to Zacks, “Gazit-Globe Ltd. is a multinational real estate company engaged in the acquisition, development and management of income-producing properties. The company focuses on necessity-driven real estate, primarily supermarket-anchored shopping centers in urban markets. In addition, the company is active in the healthcare real estate sector, owning and operating medical office buildings and senior housing businesses in North America. Gazit-Globe Ltd. is based in Tel Aviv, Israel. “

Halozyme Therapeutics (NASDAQ:HALO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $14.00 target price on the stock. According to Zacks, “Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company’s broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company’s initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme’s highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine. “

HDFC Bank Limited (NYSE:HDB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $108.00 price target on the stock. According to Zacks, “HDFC BANK’s mission is to be a World Class Indian Bank. The Bank’s aim is to build a sound customer franchise across distinct businesses so as to be the preferred provider of banking services in the niche segments that the bank operates in and to achieve healthy growth in profitability, consistent with the bank’s risk appetite. The bank aims to ensure the highest level of ethical standards, professional integrity and regulatory compliance. HDFC Bank’s business philosophy is based on four core values: Operational Excellence, Customer Focus, Product Leadership and People. “

HD Supply Holdings (NASDAQ:HDS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $35.00 price target on the stock. According to Zacks, “HD Supply Holdings, Inc. is engaged in industrial distribution primarily in North America. It operates in four segments: Facilities Maintenance, Waterworks, Power Solutions and White Cap. Facilities Maintenance distributes maintenance, repair and operations products, provides value-add services and fabricates custom products to multifamily, hospitality, healthcare and institutional facilities. Waterworks distributes complete lines of water and wastewater transmission products, serving contractors and municipalities. Power Solutions distributes electrical transmission and distribution products, power plant MRO supplies and smart-grid products, arranges materials management and procurement outsourcing for the power generation and distribution industries. White Cap distributes specialized hardware, tools, engineered materials and safety products to non-residential and residential contractors. HD Supply Holdings, Inc. is based in Atlanta, Georgia. “

Hitachi Const Mach (NASDAQ:HTCMY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Hitachi Construction Machinery Co., Ltd. engages in the manufacture, sale, service and rental of construction and industrial machinery. It operates through the Construction and Mining product segments. The companys product include mini, medium and large excavators; wheel loaders; demolition equipment; metal recycling equipment; forest machines; rigid dump trucks, compaction equipment; cranes & foundation machines and double front work machine. It also offers global e-service and mine management systems. Hitachi Construction Machinery Co., Ltd. is headquartered in Tokyo, Japan. “

I.D. Systems (NASDAQ:IDSY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $7.25 target price on the stock. According to Zacks, “I.D. Systems Inc is a leading provider of wireless solutions for corporate asset management. I.D. Systems’ customers include 3M Company, American Axle, Archer Daniels Midland, Daimler Chrysler, Deere & Co., Ford Motor Company, General Dynamics, Hallmark Cards, Northrop Grumman, Target Corporation, Walgreen Co., the U.S. Navy, the U.S. Postal Service, and the U.S. Transportation Security Administration, among others. The company’s systems enable management to control and track the location and status of their assets in real time. “

Imperial Brands PLC (NASDAQ:IMBBY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Imperial Brands PLC manufactures, markets and sells tobacco and tobacco-related products. It offers cigarettes, fine cut tobacco, papers, cigars, snus and smokeless tobacco products. Imperial Brands PLC, formerly known as Imperial Tobacco Group PLC, is based in Bristol, the United Kingdom. “

Innovus Pharmaceuticals (NASDAQ:INNV) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Innovus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. It delivers non-prescription medicine and consumer care products to improve men’s and women’s health and vitality. It has a robust portfolio of sexual dysfunction treatments, cough, cold, respiratory disease treatments and pain management medication, as well as skin care products. Its male and female sexual health and vitality products include Zestra (R) to increase desire, arousal, and satisfaction in women; EjectDelay (R) for treating premature ejaculation; Sensum+ (TM) that increases penile sensitivity; Zestra Glide (R); and Vesele (R) to maximize nitric oxide beneficial effects on sexual functions and brain health. Innovus Pharmaceuticals, Inc. is based in San Diego, California. “

iPass (NASDAQ:IPAS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “iPass Inc provides software-enabled enterprise connectivity services for mobile workers. iPass’ primary service is designed to enable enterprises to provide their employees with secure access to the enterprise’s internal network through an easy-to-use interface. “

Independence Realty Trust (NYSE:IRT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $11.00 price target on the stock. According to Zacks, “Independence Realty Trust, Inc. is a real estate investment trust. It is focused on acquiring and owning well-located garden-style and mid-rise apartment properties. The Company owns apartment properties primarily in Arizona, Colorado, Georgia, Indiana, Texas and Virginia. Independence Realty Trust, Inc. is based in United States. “

Iteris (NYSE:ITI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Iteris, Inc. is a leading provider of outdoor vision systems and sensors that optimize the flow of traffic and enhance driver safety. Iteris combines outdoor image processing, traffic engineering, and information technology to offer a broad range of transportation and safety solutions. “

Communications Systems (NASDAQ:JCS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Communications Systems manufactures and markets connectors and wiring devices for voice, data and video communications under the Suttle brand name in the United States and internationally. The company also manufactures a line of high performance fiber-optic connectors, interconnect devices and fiber cable assemblies for the telecommunications, computer and electronics markets. The company has several manufacturing plants in the United States and abroad. “